SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation of $0 in Q1 FY2026

Q1 FY2026 stock-based compensation was $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$2.79M— YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
2.79M USD
Year-over-year change
—

Stock-Based Compensation vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Stock-Based Compensation for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GKOSGlaukos CorporationLTM Jun 2026$80.22M USD+36.6%+17.9%13.1%
BLCOBausch + Lomb CorporationLTM Jun 2026$72M USD-33.9%+33.9%1.4%
OCULOcular Therapeutix, Inc.LTM Mar 2026$48.31M USD+35.8%+36.5%92.8%
ALCAlcon Inc.LTM Sep 2026$42M USD-154.5%+5.0%0.4%
RXSTRxSight, Inc.LTM Mar 2026$32.42M USD+19.7%+40.5%25.4%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$31.69M USD-0.5%+25.3%416.2%
STAASTAAR Surgical CompanyLTM Apr 2026$29.4M USD+9.3%+14.5%10.1%
OCSOculis Holding AGLTM Mar 2026CHF 18.42M CHF+63.4%+171.2%3653.8%
SGHTSight Sciences, Inc.LTM Mar 2026$11.67M USD-30.6%+0.2%14.7%
SGPSpyGlass Pharma, Inc. Common StockFY2025$2.79M USD———
Peer median (excluding SGP) —+9.3%+25.3%14.7%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.